Long-Term Effectiveness and Drug Survival of Secukinumab in Vietnamese Patients with Psoriasis: Results from a Retrospective ENHANCE Study

INTRODUCTION: Psoriasis (PsO), an immune-mediated inflammatory skin disorder, has substantial negative impact on patients’ quality of life. Secukinumab, an approved treatment for moderate-to-severe plaque PsO, has an established long-term efficacy and safety profile. This study aims to provide real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Hao Trong, Pham, Nhi Thi Uyen, Tran, Tu Nguyen Anh, Pham, Nguyen Nhat, Bui, Yen Thi, Vu, Thao Thi Phuong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884729/
https://www.ncbi.nlm.nih.gov/pubmed/36472791
http://dx.doi.org/10.1007/s13555-022-00867-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884729/
https://www.ncbi.nlm.nih.gov/pubmed/36472791
http://dx.doi.org/10.1007/s13555-022-00867-y

Ejemplares similares